Teva Pharmaceutical Industries Ltd. has rolled out donepezil hydrochloride tablets, a medication for Alzheimer’s disease. The company said Wednesday that it has received Food and Drug Administration approval to market a generic version of Eisai’s Aricept Tablets in strengths of 5 mg and 10 mg.
JERUSALEM — Teva Pharmaceutical Industries Ltd. has rolled out donepezil hydrochloride tablets, a medication for Alzheimer’s disease.
The company said Wednesday that it has received Food and Drug Administration approval to market a generic version of Eisai’s Aricept Tablets in strengths of 5 mg and 10 mg.
According to Teva, annual sales of the drug, including branded and generic sales, total approximately $2.3 billion in the United States, based on IMS Health data.
To educate others on its many benefits, the personal care brand has teamed up with board-certified physician and esteemed wellness expert, Dr. Poonam Desai.
According to Ed Morgan, president of The Emerson Group, the new series will explore the future of the retail and consumer packaged goods industries with a focus on challenging norms and driving success.
Dr. Nkrumah-Elie was selected for her extraordinary commitment to advancing science, promoting diversity, and mentoring the next generation of female leaders.
"If you have an interest in what the future holds for this industry, you're in the right place today," said Ed Morgan, president of The Emerson Group.
To educate others on its many benefits, the personal care brand has teamed up with board-certified physician and esteemed wellness expert, Dr. Poonam Desai.
Despite this gap, women pharmacy leaders are making a significant impact in their communities by adding differentiated, patient-centric services, empowering female patients to be more engaged in their care and offering support and guidance to their colleagues.
Perceptions around private brands have changed; they are no longer seen merely as generics or national brand equivalents, Doug Baker, vice president, industry relations at FMI, said in releasing the report, titled “The Power of Private Brands 2024.”
According to Ed Morgan, president of The Emerson Group, the new series will explore the future of the retail and consumer packaged goods industries with a focus on challenging norms and driving success.
